Page last updated: 2024-08-26

mci 9038 and Venous Thromboembolism

mci 9038 has been researched along with Venous Thromboembolism in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's10 (71.43)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Asmis, LM; Bachler, M; Fries, D; Koscielny, J; Lang, T; Nowak, H; Paulus, P; Schewe, JC; von Heymann, C1
Beckmann, L; Bokemeyer, C; Holstein, K; Langer, F; Lennartz, M; Poch, A1
Male, C; van Ommen, CH; Young, G1
Guo, Y; Huang, Z; Jia, L; Xing, G; Yun, X; Zou, Z1
Arepally, GM; Chong, BH; Cines, DB; Cuker, A; Greinacher, A; Gruel, Y; Linkins, LA; Morgan, RL; Mustafa, RA; Rodner, SB; Santesso, N; Selleng, S; Warkentin, TE; Wex, A1
Forman, DA; Mohanty, E; Nazir, S; Sheppard, JI; Warkentin, TE1
Bleker, SM; Büller, HR; Coppens, M; van Es, N1
Toale, KM1
Cheng, GS; Fan, FL; Ma, Q; Meng, Y; Tian, HY; Wan, HM; Wang, J; Zhang, JB1
Ortel, TL1
Ansell, JE; Lee, CJ1
Ageno, W; Streif, W1
Young, G1
Knovich, MA; Lesser, GJ; Strowd, RE1

Reviews

7 review(s) available for mci 9038 and Venous Thromboembolism

ArticleYear
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2022, Jul-01, Volume: 33, Issue:5

    Topics: Anticoagulants; Arginine; COVID-19; Critical Illness; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism

2022
New developments in parenteral anticoagulation for arterial and venous thromboembolism.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Acute Coronary Syndrome; Antithrombins; Arginine; Fondaparinux; Hirudin Therapy; Hirudins; Humans; Infusions, Parenteral; Peptide Fragments; Percutaneous Coronary Intervention; Pipecolic Acids; Polysaccharides; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Venous Thromboembolism

2013
Management of anticoagulation in the critically ill patient.
    Critical care nursing clinics of North America, 2013, Volume: 25, Issue:4

    Topics: Anticoagulants; Antithrombins; Arginine; Critical Illness; Heparin; Humans; Pipecolic Acids; Sulfonamides; Venous Thromboembolism

2013
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin

2009
Direct thrombin inhibitors.
    British journal of clinical pharmacology, 2011, Volume: 72, Issue:4

    Topics: Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Dabigatran; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Pyridines; Recombinant Proteins; Sulfonamides; Thrombin; Venous Thromboembolism

2011
Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
    Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:3-4

    Topics: Adolescent; Anticoagulants; Arginine; Benzimidazoles; beta-Alanine; Child; Child, Preschool; Dabigatran; Drug Approval; Factor Xa Inhibitors; Fondaparinux; Hirudins; Humans; Infant; Infant, Newborn; Morpholines; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Risk Factors; Rivaroxaban; Sulfonamides; Thiophenes; Thrombin; Venous Thromboembolism

2011
Old and new antithrombotic drugs in neonates and infants.
    Seminars in fetal & neonatal medicine, 2011, Volume: 16, Issue:6

    Topics: Anticoagulants; Arginine; Fondaparinux; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infant; Infant, Newborn; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Venous Thromboembolism; Warfarin

2011

Other Studies

7 other study(ies) available for mci 9038 and Venous Thromboembolism

ArticleYear
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer.
    Hamostaseologie, 2023, Volume: 43, Issue:4

    Topics: Anticoagulants; Blood Coagulation Disorders; Endometrial Neoplasms; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Neoplasm Recurrence, Local; Thromboembolism; Thrombophlebitis; Thromboplastin; Venous Thromboembolism

2023
Anticoagulation in children: Making the most of little patients and little evidence.
    Blood cells, molecules & diseases, 2017, Volume: 67

    Topics: Anticoagulants; Arginine; Blood Coagulation; Child; Drug Monitoring; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombosis; Venous Thromboembolism; Warfarin

2017
Safety and effectiveness of argatroban versus heparin for preventing venous thromboembolism after lumbar decompressive surgery.
    International journal of surgery (London, England), 2017, Volume: 44

    Topics: Adult; Aged; Anticoagulants; Arginine; Decompression, Surgical; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; Lumbar Vertebrae; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Postoperative Complications; Quality of Life; Retrospective Studies; Sulfonamides; Venous Thromboembolism; Venous Thrombosis

2017
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
    Blood advances, 2018, 11-27, Volume: 2, Issue:22

    Topics: Administration, Oral; Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Venous Thromboembolism

2018
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
    Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:5

    Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Knee; Female; Fondaparinux; Gastrointestinal Hemorrhage; Heparin; Humans; Immunoglobulins, Intravenous; Middle Aged; Pipecolic Acids; Platelet Activation; Platelet Count; Serotonin; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism

2019
[Clinical observation of heparin-induced thrombocytopenia].
    Zhonghua yi xue za zhi, 2009, May-26, Volume: 89, Issue:20

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thromboembolism; Young Adult

2009
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
    Current treatment options in oncology, 2012, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin

2012